Education
About Us
Working with TipRanks
Follow Us
PACS Group Inc (PACS)
NYSE:PACS
See the Price Targets and Ratings of:
PACS Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
$32
Buy
245.57%
Upside
Reiterated
01/07/25
Truist Financial Keeps Their Buy Rating on PACS Group Inc (PACS)
J.P. Morgan
$40→$18
Hold
94.38%
Upside
Downgraded
12/17/24
Pacs Group downgraded to Neutral from Overweight at JPMorganPacs Group downgraded to Neutral from Overweight at JPMorgan
Stephens
$48→$31
Buy
234.77%
Upside
Reiterated
11/18/24
Pacs Group price target lowered to $31 from $48 at StephensPacs Group price target lowered to $31 from $48 at Stephens
UBS
$50
Buy
439.96%
Upside
Initiated
10/09/24
PACS Group Inc: A Strong Buy on Robust Growth and Market Positioning
Guggenheim
$41→$45
Buy
385.96%
Upside
Assigned
09/11/24
Pacs Group resumed with a Buy at CitiPacs Group resumed with a Buy at Citi
Oppenheimer
$32→$40
Buy
331.97%
Upside
Assigned
08/14/24
Pacs Group price target raised to $40 from $32 at OppenheimerPacs Group price target raised to $40 from $32 at Oppenheimer
Unknown Analyst
Not Ranked
Macquarie
―
Buy
―
Initiated
06/27/24
We expect continued rapid expansion after its recent IPO, with revenue/EBITDA/EPS CAGRs of 16%/29%/33% from 2023 to 2026E.
RBC Capital
$30→$32
Buy
245.57%
Upside
Reiterated
05/14/24
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (NASDAQ: MGX), Smith Douglas Homes Corp. Class A (NYSE: SDHC) and PACS Group Inc (NYSE: PACS)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
$32
Buy
245.57%
Upside
Reiterated
01/07/25
Truist Financial Keeps Their Buy Rating on PACS Group Inc (PACS)
J.P. Morgan
$40→$18
Hold
94.38%
Upside
Downgraded
12/17/24
Pacs Group downgraded to Neutral from Overweight at JPMorganPacs Group downgraded to Neutral from Overweight at JPMorgan
Stephens
$48→$31
Buy
234.77%
Upside
Reiterated
11/18/24
Pacs Group price target lowered to $31 from $48 at StephensPacs Group price target lowered to $31 from $48 at Stephens
UBS
$50
Buy
439.96%
Upside
Initiated
10/09/24
PACS Group Inc: A Strong Buy on Robust Growth and Market Positioning
Guggenheim
$41→$45
Buy
385.96%
Upside
Assigned
09/11/24
Pacs Group resumed with a Buy at CitiPacs Group resumed with a Buy at Citi
Oppenheimer
$32→$40
Buy
331.97%
Upside
Assigned
08/14/24
Pacs Group price target raised to $40 from $32 at OppenheimerPacs Group price target raised to $40 from $32 at Oppenheimer
Unknown Analyst
Not Ranked
Macquarie
―
Buy
―
Initiated
06/27/24
We expect continued rapid expansion after its recent IPO, with revenue/EBITDA/EPS CAGRs of 16%/29%/33% from 2023 to 2026E.
RBC Capital
$30→$32
Buy
245.57%
Upside
Reiterated
05/14/24
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (NASDAQ: MGX), Smith Douglas Homes Corp. Class A (NYSE: SDHC) and PACS Group Inc (NYSE: PACS)
Best Analysts Covering PACS Group Inc
Which Analyst Should I Follow If I Want to Buy PACS and Sell After:
1 Month
xxx
Success Rate
2/3 ratings generated profit
Average Return
+8.20%
assigned a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +8.20% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
-11.23%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -11.23% per trade.
1 Year
Success Rate
0/3 ratings generated profit
Average Return
-61.33%
reiterated a buy rating 5 months ago
Copying Scott Fidel's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -61.33% per trade.
2 Years
xxx
Success Rate
0/3 ratings generated profit
Average Return
-61.33%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -61.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PACS Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
0
2
2
3
Buy
7
10
6
5
1
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
10
8
8
5
Each month's total comprises the sum of three months' worth of ratings.
PACS Stock Forecast FAQ
What is PACS’s average 12-month price target, according to analysts?
Based on analyst ratings, PACS Group Inc’s 12-month average price target is 32.00.
What is PACS’s upside potential, based on the analysts’ average price target?
PACS Group Inc has 245.57% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PACS a Buy, Sell or Hold?
PACS Group Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is PACS Group Inc’s price target?
The average price target for PACS Group Inc is 32.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $32.00 ,the lowest forecast is $32.00. The average price target represents 245.57% Increase from the current price of $9.26.
The highest analyst price target is $32.00 ,the lowest forecast is $32.00. The average price target represents 245.57% Increase from the current price of $9.26.
What do analysts say about PACS Group Inc?
PACS Group Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of PACS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.